TickerFactsScreenerDevelopers

Immunome Inc. (IMNM) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2019: $233.0K2020: $586.0K2021: $79.0K2022: $248.0K2023: $831.0K2024: $7.17M2025: $9.69M$9.69M
2019Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$9.69M+35.0%
2024$7.17M+763.2%
2023$831.0K+235.1%
2022$248.0K+213.9%
2021$79.0K-86.5%
2020$586.0K+151.5%
2019$233.0K—